ESR1 and obesity due to melanocortin 4 receptor deficiency: Investigators from the EBCTCG (Early Breast Cancer Trialists’ Collaborative Group) reported that obesity is a negative prognostic indicator in premenopausal patients with estrogen-receptor-positive breast cancer, while others have found that obesity was an adverse prognostic factor in postmenopausal breast cancer patients [8, 10].